Access Bio Gets FDA Emergency Use Authorization for Covid Tests

Aug.12 -- Reeve Benaron, chairman and interim chief executive officer at Intrivo Diagnostics, discusses the U.S. Food and Drug Administration's emergency use authorization of a Covid-19 antigen test the company distributes for Access Bio. Benaron speaks with Bloomberg's Emily Chang.